KUVATRIS THERAPEUTICS, INC. Increase (Decrease) in Deferred Revenue
KUVATRIS THERAPEUTICS, INC. reported Increase (Decrease) in Deferred Revenue of $500.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-01-14
- KUVATRIS THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2023-12-31 was $0.00.
- KUVATRIS THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2023-09-30 was $0.00.
- KUVATRIS THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2023 was $500.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $0.00 derived: sum of 2 quarters · filed 2026-01-14 | $500.00K 10-K · filed 2024-03-11 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-01-14 | $500.00K 10-Q · filed 2026-01-14 | ||
| 2023-06-30 | $500.00K 10-Q · filed 2024-09-20 |